Nichols has been studying how the amyloid-β protein interacts with a group of three proteins known as NLRP3 inflammasome to cause inflammation inside immune cells in the brain.
LATEST IN NextGen Precision Health Discovery Series
Chemistry Professor Michael Nichols discusses his research on Alzheimer’s disease as part of NextGen Precision Health’s Discovery Series
Nichols has been studying how the amyloid-β protein interacts with a group of three proteins known as NLRP3 inflammasome to cause inflammation inside immune cells in the brain.
Chemistry Professor Michael Nichols discusses his research on Alzheimer’s disease as part of NextGen Precision Health’s Discovery Series
Nichols has been studying how the amyloid-β protein interacts with a group of three proteins known as NLRP3 inflammasome to cause inflammation inside immune cells in the brain.
UMSL awarded $2.4 million grant to continue expanding Succeed Program
The funding will go toward enhancing Succeed programming, strengthening vocational and academic opportunities and improving transition services.
MORE IN NextGen Precision Health Discovery Series
LATEST NEWS
- UMSL awarded $2.4 million grant to continue expanding Succeed Program
- Finance Career Conference offers students opportunity to lead panel, fireside chat sessions
- UMSL Global International Fellowship helps faculty members deepen their research and enrich their teaching
- Eye on UMSL: Tree time
- UMSL Tritons weekly rewind
- Nursing Assistant Teaching Professor Joshua Minks helps support doctoral nursing students through Jonas Scholar Alumni Council
- Information systems student Matt Garland already working as QA analyst at Weissman
- Student Investment Trust portfolio eclipses $1 million plateau
- UMSL Addiction Science Team’s research shows overdose deaths declining in Missouri for second straight year
- Eye on UMSL: Candlelight concert
